Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group.
de Wit R, Stoter G, Sleijfer DT, Kaye SB, de Mulder PH, ten Bokkel Huinink WW, Spaander PJ, de Pauw M, Sylvester R. de Wit R, et al. Among authors: de pauw m, de mulder ph. Br J Cancer. 1995 Jun;71(6):1311-4. doi: 10.1038/bjc.1995.254. Br J Cancer. 1995. PMID: 7540039 Free PMC article. Clinical Trial.
Short-term versus long-term addition of cyproterone acetate to buserelin therapy in comparison with orchidectomy in the treatment of metastatic prostate cancer. European Organization for Research and Treatment of Cancer--Genitourinary Group.
Klijn JG, de Voogt HJ, Studer UE, Schröder FH, Sylvester R, De Pauw M. Klijn JG, et al. Among authors: de voogt hj, de pauw m. Cancer. 1993 Dec 15;72(12 Suppl):3858-62. doi: 10.1002/1097-0142(19931215)72:12+<3858::aid-cncr2820721719>3.0.co;2-6. Cancer. 1993. PMID: 8252504 Clinical Trial.
High-dose versus low-dose vinblastine in cisplatin-vinblastine-bleomycin combination chemotherapy of non-seminomatous testicular cancer: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group.
Stoter G, Sleyfer DT, ten Bokkel Huinink WW, Kaye SB, Jones WG, van Oosterom AT, Vendrik CP, Spaander P, de Pauw M, Sylvester R. Stoter G, et al. Among authors: de pauw m. J Clin Oncol. 1986 Aug;4(8):1199-206. doi: 10.1200/JCO.1986.4.8.1199. J Clin Oncol. 1986. PMID: 2426419 Clinical Trial.
Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III Study.
Stoter G, Sylvester R, Sleijfer DT, ten Bokkel Huinink WW, Kaye SB, Jones WG, van Oosterom AT, Vendrik CP, Spaander P, de Pauw M. Stoter G, et al. Among authors: de pauw m. Cancer Res. 1987 May 15;47(10):2714-8. Cancer Res. 1987. PMID: 2436756 Clinical Trial.
Mitozolomide in advanced renal cancer. A phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group.
van Oosterom AT, Stoter G, Bono AV, Splinter TA, Fossa SD, Verbaeys AJ, de Mulder PH, de Pauw M, Sylvester R. van Oosterom AT, et al. Among authors: de pauw m, de mulder ph. Eur J Cancer Clin Oncol. 1989 Aug;25(8):1249-50. doi: 10.1016/0277-5379(89)90422-7. Eur J Cancer Clin Oncol. 1989. PMID: 2767112 No abstract available.
257 results